Cyclooxygenase

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 17: Line 17:
==NSAIDs==
==NSAIDs==
-
{| border="3"
+
{| border="1"
|-
|-
! Drug
! Drug
Line 47: Line 47:
|+ Table X: Selectivity of some NSAIDs
|+ Table X: Selectivity of some NSAIDs
|}
|}
 +
 +
{| class="wikitable"
 +
! scope="col" | ×
 +
! scope="col" | Pharmacologic group
 +
! scope="col" | Drug
 +
| Salicylates || Acetylsalicylic acid
 +
|-
 +
| rowspan="2" | Propionic || Naproxen || Ibuprofen
 +
|-
 +
| 1 || 2
 +
|-
 +
| 3 || 4

Revision as of 11:11, 6 December 2010

Template:STRUCTURE 6cox

Contents

Crystal structure of COX-2

About this Structure

2I37 is a 3 chains structure of sequences from Bos taurus. Full crystallographic information is available from OCA.

NSAIDs

Drug Coefficient of selectivity (IC50Cox-1/IC50Cox-2)
Ketorolac
100-1000
Naproxen
1-10
Ibuprofen
1-10
Indometacin
1-10
Acetylsalicylic acid
1
Diclofenac
1-0.1
Valdecoxib
0.01-0.001
Etoricoxib
0.01-0.001
Table X: Selectivity of some NSAIDs
× Pharmacologic group Drug Salicylates Acetylsalicylic acid
Propionic Naproxen Ibuprofen
1 2
3 4


Reference

  • Salom D, Lodowski DT, Stenkamp RE, Le Trong I, Golczak M, Jastrzebska B, Harris T, Ballesteros JA, Palczewski K. Crystal structure of a photoactivated deprotonated intermediate of rhodopsin. Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16123-8. Epub 2006 Oct 23. PMID:17060607

Page seeded by OCA on Tue Feb 17 02:59:53 2009

  • Ghosh N, Chaki R, Mandal V, Mandal SC. COX-2 as a target for cancer chemotherapy. Pharmacol Rep. 2010 Mar-Apr;62(2):233-44. PMID:20508278
  • Rang HP, Dale MM, Ritter JM, Flower RJ. 2008. Pharmacology. Elsevier. 6th edition. 844 p.
Personal tools